Technology
Health
Biotechnology

Chimerix

$3.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (2.56%) Today
-$0.05 (-1.39%) After Hours

Why Robinhood?

You can buy or sell Chimerix and other stocks, options, ETFs, and crypto commission-free!

About

Chimerix, Inc. Common Stock, also called Chimerix, is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Read More Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

Employees
59
Headquarters
Durham, North Carolina
Founded
2000
Market Cap
183.69M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
327.05K
High Today
$3.65
Low Today
$3.50
Open Price
$3.50
Volume
405.87K
52 Week High
$5.04
52 Week Low
$1.74

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2013 IPO
US
North America

News

Seeking AlphaMay 9

Chimerix's (CMRX) CEO Mark Iwicki on Q1 2019 Results - Earnings Call Transcript

Chimerix, Inc. (NASDAQ:CMRX) Q1 2019 Earnings Conference Call May 9, 2019 8:30 AM ET Company Participants Michelle LaSpaluto – Investor Relations Mike Sherman – President and Chief Executive Officer Garrett Nichols – Chief Medical Officer Tim Trost – Chief Financial Officer Mike Andriole – Chief Business Officer Conference Call Participants Ed White – H.C. Kenneth Atkins – Cowen Operator Good morning. Welcome to the Chimerix conference call discussing the financial results of the first quarter of...

58
Yahoo FinanceMay 9

Chimerix (CMRX) Reports Q1 Loss, Tops Revenue Estimates

24
Yahoo FinanceMay 9

Chimerix Announces First Quarter 2019 Financial Results and Strategy Update

12

Earnings

-$0.47
-$0.41
-$0.35
-$0.29
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.